Evidence map›Paper›PMID 41025439›Full record

ArticleJournal of the American Heart Association2025

Huiling Li, Yufei Wei, Zhuoqi Qin, Qiyao Cheng, Yu Hong, Huibin Ru, Tingrui Song, Li Li, Xinzhong Hao, Jianhua Jin and 3 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Huiling LiDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.ORCID 0009-0008-8146-0207
Yufei WeiDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Zhuoqi QinDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Qiyao ChengDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Yu HongDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Huibin RuDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Tingrui SongDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Li LiDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.ORCID 0000-0001-9289-3974
Xinzhong HaoDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Jianhua JinDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Yan ChengDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.
Zhifang WuDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.ORCID 0000-0003-0376-982X
Sijin LiDepartment of Nuclear Medicine First Hospital of Shanxi Medical University Taiyuan China.ORCID 0000-0002-2010-3459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac allograft vasculopathy (CAV) is the primary cause of limited long-term survival among heart transplant recipients. This study aimed to evaluate the feasibility of

methodsRat models of CAV were established and 1 hour dynamic PET/CT imaging was performed in the 15th week postoperation. Serial static

resultsDynamic PET/CT imaging revealed peak graft heart (Ht) uptake in the allograft group at 60 minutes post

conclusionsWe successfully achieved molecular imaging of activated fibroblasts in CAV rat models, indicating that

Indexed as

Coronary Artery DiseaseHeart TransplantationMyocardiumPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAllograftsAnimalsDisease Models, AnimalFeasibility StudiesFibrosisFluorine RadioisotopesMaleRatsRats, Inbred LewTissue DistributionFluorine RadioisotopesRadiopharmaceuticals18F‐FAPI‐74cardiac allograft vasculopathy (CAV)fibroblast activation protein (FAP)PET/CT

Identifiers

PMID41025439
PMCPMC12684480

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.